- Home
- / Bio Preventive Medicine
Bio Preventive Medicine
Stock Price
NT$30.8
2024-10-28
Market Capitalization
NT$1.1 B
2024-10-28
Revenue
NT$2.6 M
FY, 2025
Bio Preventive Medicine Summary
Company Summary
- Overview
- Bio Preventive Medicine is a clinical-staged biotech company. It offers solutions for the prevention, screening, and monitoring of chronic diseases and cancer management.
- Type
- Public
- Status
- Active
- Founded
- 2014
- Website
- https://www.bpmbiotech.com/
- Cybersecurity rating
Table of Contents
Bio Preventive Medicine Financials
Summary Financials
- Revenue (FY, 2025)
- NT$2.6M
- Gross profit (FY, 2025)
- NT$2.4M
- Net income (FY, 2025)
- (NT$99.8M)
- Cash (FY, 2025)
- NT$250.6M
- EBIT (FY, 2025)
- (NT$100.6M)
- Enterprise value
- $995.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026